Aim: The human papillomavirus (HPV) vaccination rate in Japan fell to nearly 0% following widespread coverage of possible adverse events. Developing a next approach to promote the effective prevention of HPV-related diseases including cervical cancer (CC) in Japan requires comprehensive understanding of knowledge and attitudes regarding CC prevention, HPV infection and HPV vaccination among the population including laypersons and medical professions in Japan. Methods: A questionnaire survey was administered in a wide variety of settings in Japan. The questionnaire contained items on knowledge about CC, HPV infection and HPV vaccination; awareness of the HPV vaccine's effectiveness and associated adverse events; and attitudes toward the HPV vaccination for their daughters and for men/boys. Results: Of 3033 targeted people, complete survey responses were received from 1182 men and 1602 women (total: 2784). The male laypersons' group had significantly lower knowledge than did the female laypersons' group (adjusted odds ratio, aOR = 3.86, P < 0.001). Compared with the male laypersons' group, the female laypersons' group tended to have less positive attitudes toward HPV vaccination for their daughters (aOR = 0.78, P = 0.006), but the female laypersons' group showed more positive attitudes toward vaccinating men/boys (aOR = 1.93, P < 0.001).
Introduction
Human papillomavirus (HPV) causes various types of diseases, both benign and malignant. Vulvar and laryngeal papillomas are representative of the benign diseases caused by HPV. HPV-related cancers include cervical cancers (CC), as well as vaginal, vulvar, anal, penile, oropharyngeal and oral cancers. The importance of primary and secondary prevention of HPVrelated diseases has become a worldwide concern in the current decade, not only for women but also for men. 1 The number of CC patients in Japan has gradually increased. The incidence of CC was estimated at 7868 in 2000, 8474 in 2005, 10 737 in 2010 and 10 520 in 2013. 2 In this context, it was necessary to promote a CC prevention program as soon as possible. In October 2009, the Japan Society of Obstetrics and Gynecology strongly recommended HPV vaccination for girls aged 11-14 years. 3 The Japanese Ministry of Health, Labour and Welfare (MHLW) began an HPV vaccination program for young girls, with financial support, in 2011, and the Ministry's formal national HPV vaccine program began in April 2013. 4 The program has continued since then; however, only 3 months after the program's initiation, in June 2013, the MHLW suspended its recommendation of HPV vaccination because of widespread public suspicion of adverse events, especially chronic general pain and/or motor disorder after receiving the vaccination. This situation has been projected to cause an enormous negative future impact on the prevention of CC and HPV-related diseases in Japan. 4 It was also reported that 186 women (0.005% of all of those vaccinated) had not recovered from the adverse events at the time of a national investigation in 2015. 5 Most of the adverse events were considered to be caused by functional somatic syndrome. These cases were reported repeatedly and widely in the media, including television, radio, newspapers and magazines, as adverse reactions. As a result of this media coverage, many Japanese people began to feel anxiety and distrust toward the HPV vaccine. In a recent study, symptoms similar to those that were thought to be adverse events were observed in participants irrespective of HPV vaccination status. 6 Furthermore, other researchers have demonstrated that there has been no significant increase in the occurrence of any of the 24 reported post-HPV vaccination symptoms. 7 Nevertheless, the proactive recommendation for the national HPV vaccine program has yet to be reissued.
To construct an appropriate strategy for improving the prevention of HPV-related diseases in Japan, we need to know the current state of knowledge and attitudes regarding HPV-related disease prevention. We sought to investigate and clarify attitudes toward CC prevention, HPV infection and HPV vaccination among the general population. In addition, we aimed to test our hypothesis that men in Japan would be indifferent to HPV infection and CC.
Methods

Participants and settings
We conducted our study from October 2015 to June 2016 in various settings. In total, the study was conducted in 21 locations, including public spaces, classrooms, company offices, university festivals, citizens' open forums and an academic meeting. We recruited male and female participants aged over 16 years to complete a questionnaire after providing their consent. We explained the questionnaire survey verbally and used printed information for those who attended the meetings and events. We confirmed participants' submission of the completed questionnaire, including the provision of consent. A street survey was conducted in the public events space at Yokohama Station on Wednesday, May 18, 2016 and Sunday, June 12, 2016. Classroom surveys of the following groups were also conducted: fifth-year students at Yokohama City University Medical School, first-and second-year students in the Kanagawa University Faculty of Human Sciences, third-year students in the International College of Arts and Sciences at Yokohama City University, and the general student bodies of three nursing schools in Tokyo Prefecture, Saitama Prefecture and Niigata Prefecture. Seven cooperating companies were selected based on the following three criteria: having at least 10 employees, being located in Yokohama City, and giving consent by phone, e-mail and/or visitation. Furthermore, questionnaires were administered at various locations and in multiple situations, such as a medical college festival at Yokohama City University; four citizens' open forums in the cities of Yokohama, Osaka and Niigata; and a cytology conference in Kanagawa Prefecture.
Questionnaire
A questionnaire to measure attitudes and knowledge regarding CC, HPV and HPV vaccination was created based on existing questionnaire surveys, [8] [9] [10] [11] [12] including a previous study conducted by our research group. We adopted a ready-made scoring sheet, SN-0289 (SCANET Co., Ltd). The questionnaire included a total of 11 items assessing knowledge: 6 questions about CC, 3 questions about HPV infection and 2 questions about HPV vaccination. These 11 items consisted of 8 true-false statements and 3 multiplechoice questions. We explained how to fill in the questionnaire to participants verbally, but once they began to record their answers we did not intervene. To measure awareness of the effectiveness and adverse events associated with HPV vaccination, the following questions were incorporated: 'Are you aware of any positive effects of the HPV vaccine?' and 'Are you aware of any adverse events associated with the HPV vaccine?' The following questions measured motivation to undergo HPV vaccination: 'If you have/had a daughter, do/would you want her to be vaccinated against HPV?' and 'Do you think men/boys should be vaccinated against HPV?'
The questionnaire also included items on demographic characteristics such as sex (male, female), profession, age, marital status (married, unmarried), sexual experience (experienced, not experienced, declined to answer), time since the last Papanicolaou smear (never, <2, 2-5, >5 years, unknown) and HPV vaccination status (already vaccinated, not yet vaccinated, unknown). The questions about last Papanicolaou smear and HPV vaccination status were answered only by female participants. Participants were able to choose from the following 17 professions: (1) medical school student; (2) nursing school student; (3) other medical student; (4) nonmedical college/university student; (5) high school student; (6) other student; (7) medical doctor; (8) nurse, public health nurse, and/or midwife; (9) pharmacist; (10) medical laboratory technician; (11) other medical professional; (12) office worker; (13) teacher; (14) civil servant; (15) stay at home spouse; (16) part time worker or (17) other. Professions 1-3 and 7-11 were categorized as the medical profession group. Other professions were defined as the laypersons' group.
Participants filled out a 20-question, multiplechoice, anonymous questionnaire. Completing the survey took approximately 5-10 min. Eleven questions regarding knowledge were scored and divided into three groups by tertiles: low (0-4 points), medium (5-7 points) and high (8-11 points) .
Statistics
The statistical analysis was performed using Student's t-test, the χ 2 test, and binominal logistic regression analysis. Odds ratios and age-, marital-status-, sexexperience-and sex-adjusted odds ratios (aOR) from the binominal logistic regression were analyzed to assess differences in knowledge and attitudes among four subgroups: male laypersons, female laypersons, male medical professionals and female medical professionals. Age (categorized into the following age groups: 16-19, 20-29, 30 -39, 40-49, 50-59 and ≥60 years), marital status, and sexual experience were included as covariates in the subgroup analysis conducted using binominal logistic regression. Sex was added as a covariate in the analysis of the knowledge level groups. Values of P < 0.05 were defined as significant. All statistical analyses were performed using SPSS, version 22 (IBM Corporation).
Ethics approval
This study protocol was approved by the Institutional Ethics Committee of Yokohama City University School of Medicine.
Results
Recruitment
We administered the questionnaire survey on 21 occasions, resulting in a total of 3033 returned questionnaires. Of these, 249 questionnaires with missing information on age, sex and/or profession were excluded from the analysis. The details of each group of questionnaire surveys are shown in Table 1 . We collected a large number of responses, especially in classrooms, companies and public spaces. The sample size for the classroom survey was as follows: 68 in a medical school, 314 in three nursing schools and 447 in two other universities.
Characteristics
Characteristics of the participants are shown in Table 2 . A total of 2784 participants were analyzed, including 1182 men and 1602 women. The age distribution was different for men and women (P = 0.004):
The proportion in their 40s was higher for women than for men (21.5% vs 17.8%), and the proportion in their 50s was significantly higher for men than for women (16.0% vs 11.9%). The proportion of medical professionals was 13.5% for men and 29.2% for women. Overall, the proportion of participants in medical professions was 22.6%, and the proportion of participants in nonmedical professions (laypersons) was significantly higher, at 77.4% (P < 0.001).
The proportion who were married was higher for men than for women (P < 0.001). About 67% of women aged over 20 years had undergone a Papanicolaou test of the cervix. The HPV vaccination rate among women was 33.5% in those in their teens or 20s.
Participants' knowledge of HPV, CC and prevention
The correct answer rates for each question gauging knowledge of CC screening, HPV and HPV vaccination are shown in Figure 1 . For all 11 questions, women had significantly higher correct answer rates than did men (P < 0.001), and medical professionals had significantly higher correct answer rates than did laypersons (P < 0.001). The correct answer rates for individual questions among all participants ranged from 7.2% (Question 9) to 82.9% (Question 1). Knowledge levels among the groups are shown in Table 3 . In the medical group, there were no differences in knowledge level between male and female participants (P = 0.302), whereas, in the laypersons' group, women had a significantly higher overall knowledge level than did men (P < 0.001). The three subgroups of female laypersons, male medical professionals and female medical professionals had significantly higher knowledge levels than did the male laypersons' group (aOR = 3.86, 16.73 and 18.06, respectively).
Awareness of the effectiveness and adverse events associated with the HPV vaccine
The results for awareness of the effectiveness of HPV vaccination and postvaccination adverse events are shown in Table 4 . Awareness of the effectiveness of the vaccine was significantly higher in the female laypersons' group than in the male laypersons' group (aOR = 2.45, P < 0.001). Awareness of the effectiveness was significantly higher in male professionals (aOR = 5.29, P < 0.001) and female medical professionals (aOR = 6.47, P < 0.001) than in the male laypersons' group. Comparing knowledge levels, the high knowledge level group had a significantly higher awareness of the effectiveness of the vaccine than did the low knowledge level group (aOR = 9.64, P < 0.001).
Awareness of adverse events after HPV vaccination was significantly higher in the female laypersons' group than in the male laypersons' group (aOR = 3.93, P < 0.001). Awareness of adverse events was significantly higher in male professionals (aOR = 6.55, P < 0.001) and female medical professionals (aOR = 14.38, P < 0.001) than in the male laypersons' group. Comparing knowledge levels, the high knowledge level group had a significantly higher awareness of adverse events than did the low knowledge level group (aOR = 14.62, P < 0.001).
Attitudes toward HPV vaccination
About half of all participants were undecided with regard to a stance on HPV vaccination for their real or hypothetical daughters or for boys and men (Table 5 ). However, the female laypersons' group tended to have less positive attitudes toward HPV vaccination for their real or hypothetical daughters, compared with the male laypersons' group (aOR = 0.78, P = 0.006). In contrast to their negative attitudes toward HPV vaccination for their real or hypothetical daughters, the female laypersons' group showed the most positive attitudes toward vaccinating boys and men (aOR = 1.93, P < 0.001). Comparing knowledge levels, attitudes toward vaccinating real or hypothetical daughters were significantly more positive in the high knowledge level group than in the low knowledge level group (aOR = 2.66, P < 0.001). These groups' attitudes toward vaccinating boys and men were similar to their attitudes toward vaccinating their own daughters.
Discussion
To our knowledge, this is the largest questionnaire survey study including male participants to investigate knowledge and attitudes regarding CC prevention, HPV and HPV vaccination among Japanese people. As expected, the present study revealed that the Japanese population in general-and especially males in nonmedical professions-had low levels of knowledge and awareness of HPV and HPV vaccination. Awareness of adverse events after HPV vaccination was clearly higher than awareness of the vaccine's effectiveness, and this was assumed to be because of the influence of the mass media in Japan (e.g., TV reports, newspapers and magazines). 4, 13 The HPV vaccine is referred to as a 'cervical cancer preventive vaccine' in Japan, and this is considered one of the reasons that Japanese men tend to think that the HPV vaccine and CC are not related to them personally. This situation is one of the major obstacles to achieving high HPV vaccination rates in Japan, in line with those in other parts of the developed world. 14 We have launched a new website that provides easyto-understand information on scientific journals and topics (http://kanagawacc.jp/) in Japanese to introduce important scientific facts. Although a number of questionnaire surveys have been conducted to investigate knowledge and attitudes toward HPV prevention, selection bias tends to be a problem because of the types of target groups used for recruitment, such as Internet users, 8 new female college students 9 and a university-hospitalbased community. 10 In the present survey, we planned to obtain data from people from diverse generations and professions to the extent possible to reduce such selection bias. To achieve this, we collected questionnaires from the various companies and carried out events in a public space (Yokohama Station), with support from several volunteers, including a CC survivor. We provided leaflets about general cancer prevention and small low-priced gifts (e.g., handkerchiefs, sweets, drinks or toys), mainly for the participants with children, to recruit as many representatives of the general population as possible. In this way, we sought to recruit participants who did not have a particular interest in cancer prevention and/or health issues.
Although several questionnaire surveys about HPV prevention among Japanese mothers have been reported, 13 these previous studies did not include questions about male involvement in HPV prevention or about whether boys and men should also be vaccinated, and only a few surveys researching the awareness of HPV prevention have focused on men. 11, 12, 15, 16 A study that targeted 27 fathers living in Japan found that they had poor knowledge but a high acceptance of HPV vaccination, 15 similar to our findings. The authors of this previous work stressed the importance of active male involvement in CC prevention strategies. Another questionnaire study examined attitudes toward HPV vaccination among 378 German men, finding that approximately 74% of these men wanted to be inoculated with the vaccine. 16 A questionnaire study of 14-24-year-old boys and men in Italy found that 58.2% of nonvaccinated participants were willing to receive the vaccine. 12 However, in our study, only 26% of male participants responded that they thought that boys and men should be vaccinated (Table 5 ). There may be differences in the survey methods used, but the awareness of men in Japan regarding HPV prevention was estimated to be extremely low, compared with that of men in Western countries. A Korean questionnaire study showed that only 25.1% of men wanted to receive the HPV vaccine. 17 Korea and Japan have years), marital status, sex and sexual experience were included as covariates in the adjusted OR. P-value estimated using binomial logistic regression analysis. OR, odds ratio; CI, confidence interval. Table 4 Comparison of awareness of the effectiveness and adverse events associated with HPV vaccination among subgroups and knowledge level groups 4 because of the ongoing discussion of adverse events by the MHLW, the willingness of the general population to undergo HPV vaccination was relatively high, at about 41% in the total sample (Table 5 ). This finding is contrary to our estimation before the study. The data clearly showed that a certain number of people understand the importance of the HPV vaccine. However, we also revealed that the female laypersons showed significantly more negative attitudes toward inoculating their daughters with the HPV vaccine than did male laypersons (aOR = 0.78, P = 0.006). In contrast, these women showed a more positive attitude than did their male counterparts toward the inoculation of men and boys (aOR = 1.93, P < 0.001). Because women knew more about adverse events following HPV vaccination than did men, they seemed to think the vaccine was dangerous for their daughters, despite understanding its necessity. However, they might have expressed mixed feelings, in that they did not want their daughters to be infected with HPV from men.
It has been reported that knowledge and awareness alone do not lead people to take actual action in terms of self-change processes. 18 In self-change processes, raising awareness and taking action are different steps, and the approach for each step should be distinguished. Social marketing strategies are considered an effective means of public health intervention. 19 Applying these concepts to HPV vaccination programs is essential for eliminating nonscientific concerns about adverse events and making people realize the necessity of HPV vaccination, as part of the aim of normalizing the HPV vaccine program in Japan. Japan has a successful history of health promotion using social marketing strategies to increase the recognition of metabolic syndrome to over 95% among men, 20 thereby reducing mortality from cardiovascular diseases. Combining these approaches and our results, we strongly appeal to both academic societies and the government to implement a broad awareness campaign to help Japanese citizens understand the risks of HPV infection and related diseases. Such campaigns should target not only girls and women, but also boys and men, from early adolescence to adulthood.
This study has several limitations regarding the method of the questionnaire. First, the study was conducted using a questionnaire created especially for this research, and therefore it is difficult to objectively assess each question's correct answer rate compared with other study data. It might have been advantageous to perform a pilot study using a questionnaire with standardized content before moving on to largescale studies. Another limitation is selection bias, in that the participants might have had more interest in health promotion, HPV, or CC, compared with the general population, despite the fact that the questionnaire was administered to members of the general population and those in nonmedical professions as much as possible. Furthermore, conducting the survey in the limited places and on the limited occasions chosen by the researchers may also have led to selection bias.
In keeping with the recommendations of the Centers for Disease Control and Prevention 21 and the Advisory Committee on Immunization Practices, 22 vaccination of both sexes is already becoming a global standard. 23, 24 Considering the importance of the effective prevention of HPV infection not only in Japan but also in other countries with low HPV vaccination coverage, as well as problems concerning adverse events, male involvement is indispensable to changing the situation. In Ireland, a country whose HPV vaccination crisis is similar to Japan, a nationwide media campaign has led to improved vaccination rates. 25 We are planning to conduct a randomized trial to examine how educational intervention can change male attitudes toward HPV prevention.
In conclusion, the results of this large-scale questionnaire survey indicated that the general population of men in Japan lacked knowledge and awareness of HPV-related disease prevention as represented by CC prevention. However, men generally showed more positive attitudes toward HPV vaccination for their daughters than did women. Increasing male involvement in HPV prevention is an important step toward achieving the goal of preventing HPV-related diseases. Therefore, a new educational approach, irrespective of sex, to provide accurate information including material on international circumstances is urgently needed.
